{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Brea",
      "state": "CA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "83583",
      "recalling_firm": "Beckman Coulter Inc.",
      "address_1": "250 S Kraemer Blvd",
      "address_2": "",
      "postal_code": "92821-6232",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distribution was nationwide.  There was government and military distribution.  Foreign distribution was made to Canada.",
      "recall_number": "Z-0210-2020",
      "product_description": "Beckman Coulter Lipase, REF OSR6130 and OSR6230.",
      "product_quantity": "20,926 units",
      "reason_for_recall": "NAPQI, a metabolite of Acetaminophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients.",
      "recall_initiation_date": "20180824",
      "center_classification_date": "20191024",
      "termination_date": "20240802",
      "report_date": "20191030",
      "code_info": "All lots",
      "more_code_info": ""
    }
  ]
}